Form 4 Filing for Edward M. Kaye - CYTOKINETICS INC

This filing details a transaction by Edward M. Kaye, a director at CYTOKINETICS INC. On April 15, 2026, Mr. Kaye acquired 191 shares of common stock under the Director Equity in Lieu of Cash Retainer Program. These shares were fully vested at the time of the grant. The acquisition price was $65.37 per share. Following this transaction, Mr. Kaye holds a total of 10,365 shares of common stock, all of which are directly owned. The transaction code "A" indicates an acquisition, and the "D" in ownership nature signifies direct ownership.